ACE2 trials suggest remodeling, not dilation, as primary therapeutic effect

Pulm Circ. 2022 Jan 20;12(1):e12022. doi: 10.1002/pul2.12022. eCollection 2022 Jan.
No abstract available

Publication types

  • Editorial